Fine Vision
Nanjing
About Fine Vision
Fine Vision is a company with R&D facilities in Nanjing and Wuhan that focuses on femtosecond laser application research in the fields of ocular surgery and biomaterial processing. The entire femtosecond laser corneal refractive surgery equipment, its first commercially available item, was developed by the university's Wuhan Optoelectronics National Research Center under the Huazhong Technology Technology transition.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $7.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2025)
Industries & Categories
Eyewear, Health Care, Medical
Canonical: https://fsome.com/organization/fine-vision-97279 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.